秒速时时彩

You are here: Home> News> Company News
  • 28

    2020-02

    Letter of Announcement on the Research Project of 2020 Young Talents Training Program for Young and Young Doctors of Osteoporosis and Bone Mineral Salt Diseases and the Bethune · Stone Medicine Research Fund Project

    From 2019, co-sponsored by the Chinese Medical Association's Osteoporosis and Bone Mineral Diseases Branch and the Bethune Public Welfare Foundation, with the support of CSPC Ouyi Pharmaceutical Co., Ltd., the “Osteoporosis and Bone Mineral Salt Diseases Young and Middle-aged The Doctor Excellent Talent Training Program and the Bethune • Shi Yao Osteoporosis Research Fund "are carried out in the form of donating innovative clinical research or basic research on osteoporosis. ...

  • 27

    2020-02

    Children with leukemia successfully treated during children's hospital outbreak

    Since the outbreak in January this year, the Blood Center of Hebei Children's Hospital of Integrated Traditional Chinese and Western Medicine has taken the risk to safely and successfully perform stem cell transplantation for three children with leukemia. ...

  • 26

    2020-02

    Provincial Leading Group for New Coronary Pneumonia Epidemic Sends Appreciation Letter to CSPC

    On February 24, the material security team of Hebei Province's Leading Group for Response to the New Coronavirus Infection and Pneumonia Epidemic was entrusted by the Provincial Party Committee and the Provincial Government to send a "Thank You Letter" to CSPC. ...

  • twenty three

    2020-02

    CSPC donates more than 4 million yuan to Wuhan medical staff

    On February 21, CSPC, through the China Population Welfare Foundation, donated 90,000 boxes of Guoweikang Vitamin C worth RMB 4.32 million to the majority of medical staff in the front line of Wuhan. ...

  • twenty one

    2020-02

    The production task of 200,000 boxes helped the front line, and Shi Yaoren promised to complete it!

    On February 18, CSPC responded to the call of the State Council and undertook all the difficulties to undertake the production of 200,000 boxes while the country's drug supply was still very tight. ...

  • 19

    2020-02

    Our love is always online and never far away

    With the deployment of the group, branches in various places have given out a helping hand in accordance with the actual needs of the local front line to fight the epidemic. ...

  • 18

    2020-02

    Hu Bijie, member of the National Expert Group, recognizes Abidol's anti-epidemic effect

    On February 17, "Xinmin Evening News" published the article "Shanghai Medical Regulations will be released as soon as this week", interviewing Hu Bijie, a member of the national and Shanghai two-level expert groups. Hu Bijie revealed in the interview that Abidol was used in anti-epidemic drugs. Have a certain effect. ...

  • 13

    2020-02

    Wuhan Tongji Hospital consensus on diagnosis and treatment of severe new coronary pneumonia includes Abidol as recommendation

    In Article 9 "Recommendations for the Treatment of Severe and Critical Patients", it is clearly pointed out that Abidol tablets can be used for antiviral treatment of patients with common type (including severe high-risk factors), severe and critical neo-pneumonitis. ...

  • 12

    2020-02

    Shi Yao Lorite ™-Erlotinib Hydrochloride

    Recently, Lorete ™ has been officially launched as domestic erlotinib. It is powerful and classic, and shines, bringing more choices to the majority of patients with non-small cell lung cancer. ...

  • 11

    2020-02

    Governor Xu Qin came to CSPC to investigate and hoped that he would work hard to win double victory!

    Governor Xu Qin expressed his hope that CSPC will fully produce the drugs involved in the epidemic, support Wuhan and Hubei, and supply the province at the same time. ...

  • 10

    2020-02

    Helping to fight the new crown pneumonia epidemic

    The epidemic is severe and affects people. CSPC Group, while fully protecting the front-line supply of new-type coronavirus pneumonia medicines, shoulders its social responsibilities, raises relief materials in various directions, and donates these materials to the urgently needed front as soon as possible. Contributing to win the epidemic. ...

  • 07

    2020-02

    The fifth edition of the diagnosis and treatment program is very strong

    On February 4th, the National Health and Medical Commission issued the "Diagnosis and Treatment of Pneumonia of New Coronavirus Infection (Trial Version 5)". Huoxiangzhengqi is a recommended Chinese patent medicine for the treatment of fatigue and gastrointestinal discomfort during clinical observation period. . ...

  • 05

    2020-02

    Academician Li Lanjuan confirms that Abidol can suppress the new crown Qi effect and attract national attention

    On February 4, China's new crown virus research ushered in major progress. The academician of the Chinese Academy of Engineering and a member of the high-level expert group of the National Health and Medical Commission of China Li Lanjuan's team announced the latest research results of pneumonia in the treatment of new coronavirus infection in Wuhan, confirming Abidol. Can effectively inhibit new coronavirus. ...

  • 05

    2020-02

    The latest research result of Academician Li Lanjuan's team: Abidol can effectively inhibit coronavirus

    The results of this study further confirmed the inhibitory effect of Abidol on coronavirus. ...

  • 03

    2020-02

    Together to fight the epidemic, CSPC started the "war epidemic"!

    On February 3, in order to provide better support for the fight against the new type of coronavirus pneumonia in China, CSPC employees started work in full swing, concentrated their efforts on production and operation, and implemented a series of measures to go all out Epidemic prevention and control work. ...